SpineFrontier earns FDA approval for A-CIFT SoloFuse HA Standalone System: 3 things to know

SpineFrontier earned FDA approval for its A-CIFT SoloFuse HA fusion technology.

Advertisement

Here are three things to know:

1. The A-CIFT SoloFuse HA standalone system is designed to offer an alternative to traditional plating.

2. The system features PEEK-OPTIMA with hydroxyapetite. Invibio’s biomaterial PEEK-OPTIMA HA Enhanced is designed to promote bone formation and high-quality new bone bridging.

3. When used with SpineFrontier’s angled driver technology, the A-CIFT SoloFuse HA is intended to limit tissue disruption.

More articles on surface technology:
Centinel Spine receives FDA 510(k) clearance for its FLX Platform of 3D-printed all-titanium devices: 4 insights
Camber Spine receives FDA clearance for titanium ALIF device: 3 insights
Oxford Performance Materials teams up with JSR Corp. to advance PEKK line in Asia: 4 insights

 

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.